Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 3 18Phase 1 5Phase NA 2Phase 4 2Phase 1/2 2Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Sexuality 1Osteoporosis 1Neoplasms, Hormone-Dependent 1Fractures, Bone 1Bone Diseases, Metabolic 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Aromatase Inhibitors × Clear all
NCT05362760 2025-05-16

MINERVA

University of Ulm

Phase 4 Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡